Uhakika Bro
JF-Expert Member
- Mar 29, 2022
- 3,644
- 4,315
These results reflects the way things are as of today October 17, 2024.
This report provides a breakdown of medicinal products registered in Tanzania, focusing on the product categories and performance of key manufacturers. The data highlights significant trends in the production of pharmaceuticals, antiseptics, and other medicinal products.
1. Product Category Distribution
The classification of registered products reveals that:
Human Medicinal Products dominate the market, making up 44.48% of the total registered products. This category includes medicines specifically formulated for human consumption.
Antiseptics and Disinfectants combined account for 40.79% of all made in Tanzania medicines. Antiseptics alone make up 13.32%, Disinfectants make up 4.53% and lastly those classified as antiseptics/disinfectants takes up 22.95% of all products. These products are essential for infection control, especially in healthcare settings and everyday use, which reflects their strong market presence. Seems also that the coronavirus epidemic stimulated rapid expansion of this market in the years2020-2022.
Veterinary Medicinal Products constitute 13.03%, emphasizing the need for medical solutions catering to animal health.Herbal Medicinal Products, although significant in traditional medicine, only make up 0.85% (approximately 1%) of the total products.
Biologicals and Vaccines represent a small but critical segment, comprising only 0.85% (approximately 1%) of the market.2. Performance of Manufacturers
The competition among manufacturers is intense, with a few companies leading the market in terms of the number of registered products:
Shelys Pharmaceuticals Limited stands out as the top performer, with 54 registered products, demonstrating a strong foothold in the Tanzanian pharmaceutical market.
Prince Pharmaceuticals Company Limited maintains a competitive position with 41 products. This company has a diverse portfolio that spans multiple categories, including Human Medicinal Products, Antiseptics/Disinfectants, and Herbal Medicinal Products. Notably, it is the only manufacturer with registered products in the herbal medicine category.
Zenufa Laboratories (T) Limited follows closely with 39 registered products, primarily focusing on human medicines.
Farmers Centre Limited leads in the production of veterinary medicines, with 32 products currently on the market. Veterinary deworming agents are produced by Farm Access Limited, which has 4 products.
Hester Biosciences Africa Limited is the main producer of veterinary vaccines in Tanzania, with 11 registered products. Additionally, NOVEL VACCINES AND BIOLOGICALS COMPANY LTD. (NOVAB) has one registered product, the TatuMoja vaccine.
There is a significant presence of producers specializing in infusions for human medicines, including Kairuki Pharmaceutics Industry Limited with 21 products and Alfa Pharmaceuticals Limited with 8 products.
SRI BALAJI PHARMA LIMITED has registered 30 products, mainly focusing on Antiseptics/Disinfectants and some topical human medicinal products, a category also produced by A.A Pharmaceuticals Limited with 8 registered products.Finally, the remaining 104 products are antiseptics, disinfectants, and sanitizers produced by various manufacturers.
3. Key Observations: Antiseptic demand appears to be significant, with a combined total of more than 40% of the market focused on infection control products (antiseptics, disinfectants, and similar categories). Veterinary products take a notable share, reflecting the agricultural and livestock importance in Tanzania.
Herbal and vaccine products are underrepresented, pointing to a potential area of growth in the promotion of traditional medicines and biological advancements.
Conclusion
The Tanzanian medicinal product market is heavily concentrated on human health, with antiseptics and human medicines taking up the largest share. However the demand and need of antiseptics reflected is still controversial and up to debate (what do YOU say)?
The leading manufacturers like Shelys Pharmaceuticals Limited are setting the pace, while the modest presence of herbal medicines suggests room for expansion, especially in light of the country’s rich tradition of herbal healthcare. There is also a growing need for vaccines and biologicals, especially in response to global health trends.
This report aims to inform stakeholders, including traditional healers, pharmaceutical manufacturers, and policymakers, about the current state of the market and areas for future development.
October 17, 2024
This report provides a breakdown of medicinal products registered in Tanzania, focusing on the product categories and performance of key manufacturers. The data highlights significant trends in the production of pharmaceuticals, antiseptics, and other medicinal products.
1. Product Category Distribution
The classification of registered products reveals that:
Human Medicinal Products dominate the market, making up 44.48% of the total registered products. This category includes medicines specifically formulated for human consumption.
Antiseptics and Disinfectants combined account for 40.79% of all made in Tanzania medicines. Antiseptics alone make up 13.32%, Disinfectants make up 4.53% and lastly those classified as antiseptics/disinfectants takes up 22.95% of all products. These products are essential for infection control, especially in healthcare settings and everyday use, which reflects their strong market presence. Seems also that the coronavirus epidemic stimulated rapid expansion of this market in the years2020-2022.
Veterinary Medicinal Products constitute 13.03%, emphasizing the need for medical solutions catering to animal health.Herbal Medicinal Products, although significant in traditional medicine, only make up 0.85% (approximately 1%) of the total products.
Biologicals and Vaccines represent a small but critical segment, comprising only 0.85% (approximately 1%) of the market.2. Performance of Manufacturers
The competition among manufacturers is intense, with a few companies leading the market in terms of the number of registered products:
Shelys Pharmaceuticals Limited stands out as the top performer, with 54 registered products, demonstrating a strong foothold in the Tanzanian pharmaceutical market.
Prince Pharmaceuticals Company Limited maintains a competitive position with 41 products. This company has a diverse portfolio that spans multiple categories, including Human Medicinal Products, Antiseptics/Disinfectants, and Herbal Medicinal Products. Notably, it is the only manufacturer with registered products in the herbal medicine category.
Zenufa Laboratories (T) Limited follows closely with 39 registered products, primarily focusing on human medicines.
Farmers Centre Limited leads in the production of veterinary medicines, with 32 products currently on the market. Veterinary deworming agents are produced by Farm Access Limited, which has 4 products.
Hester Biosciences Africa Limited is the main producer of veterinary vaccines in Tanzania, with 11 registered products. Additionally, NOVEL VACCINES AND BIOLOGICALS COMPANY LTD. (NOVAB) has one registered product, the TatuMoja vaccine.
There is a significant presence of producers specializing in infusions for human medicines, including Kairuki Pharmaceutics Industry Limited with 21 products and Alfa Pharmaceuticals Limited with 8 products.
SRI BALAJI PHARMA LIMITED has registered 30 products, mainly focusing on Antiseptics/Disinfectants and some topical human medicinal products, a category also produced by A.A Pharmaceuticals Limited with 8 registered products.Finally, the remaining 104 products are antiseptics, disinfectants, and sanitizers produced by various manufacturers.
3. Key Observations: Antiseptic demand appears to be significant, with a combined total of more than 40% of the market focused on infection control products (antiseptics, disinfectants, and similar categories). Veterinary products take a notable share, reflecting the agricultural and livestock importance in Tanzania.
Herbal and vaccine products are underrepresented, pointing to a potential area of growth in the promotion of traditional medicines and biological advancements.
Conclusion
The Tanzanian medicinal product market is heavily concentrated on human health, with antiseptics and human medicines taking up the largest share. However the demand and need of antiseptics reflected is still controversial and up to debate (what do YOU say)?
The leading manufacturers like Shelys Pharmaceuticals Limited are setting the pace, while the modest presence of herbal medicines suggests room for expansion, especially in light of the country’s rich tradition of herbal healthcare. There is also a growing need for vaccines and biologicals, especially in response to global health trends.
This report aims to inform stakeholders, including traditional healers, pharmaceutical manufacturers, and policymakers, about the current state of the market and areas for future development.
October 17, 2024
